Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.96 |
| ▸ | PARP1 | P09874 | 8/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.46 |
| ▸ | RECQL | P46063 | 2/20 | 0.46 |
| ▸ | JAK2 | O60674 | 1/20 | 0.44 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.44 |
| ▸ | MELK | Q14680 | 1/20 | 0.44 |
| ▸ | STK24 | Q9Y6E0 | 1/20 | 0.44 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | DAO | P14920 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | TYMS | P04818 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29448530 | 0.98 | ALDH1A1 (1.00) | ALDH1A1PARP1TDP1RECQLJAK2 | |
| SCHEMBL27034083 | 0.98 | ALDH1A1 (1.00) | ALDH1A1PARP1TDP1RECQLJAK2 | |
| SCHEMBL20086 | 0.98 | ALDH1A1 (1.00) | ALDH1A1PARP1TDP1RECQLJAK2 | |
| Potassium SCHEMBL1315293 | 0.96 | ALDH1A1 (0.96) | ALDH1A1PARP1TDP1RECQLJAK2 | |
| Hydrochloric Acid SCHEMBL7117065 | 0.96 | ALDH1A1 (0.96) | ALDH1A1PARP1TDP1RECQLJAK2 | |
| SCHEMBL25429670 | 0.96 | ALDH1A1 (0.96) | ALDH1A1PARP1TDP1RECQLJAK2 | |
| Lithium SCHEMBL1315235 | 0.96 | ALDH1A1 (0.96) | ALDH1A1PARP1TDP1RECQLJAK2 | |
| SCHEMBL1316616 | 0.96 | ALDH1A1 (0.96) | ALDH1A1PARP1TDP1RECQLJAK2 | |
| Water SCHEMBL18317911 | 0.96 | ALDH1A1 (0.96) | ALDH1A1PARP1TDP1RECQLJAK2 | |
| SCHEMBL49588 | 0.96 | ALDH1A1 (0.96) | ALDH1A1PARP1TDP1RECQLJAK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2389364-B1 | NEW METHOD FOR OBTAINING 5-AMINO-2,3-DIHYDROPHTHALAZINE-1,4-DIONE ALKALI METAL SALTS AND THEIR USE IN MEDICINE | ABIDOPHARMA PL SP Z O O (PL) | 2016-10-26 | — | — | EP | claimed |
| EP-3072888-A1 | USE OF 5-AMINO-2,3-DIHYDROPHTHALAZINE-1,4-DIONE ALKALI METAL SALTS IN MEDICINE | Abidopharma PL Sp. z o.o. (PL) | 2016-09-28 | — | — | EP | claimed |
| US-9101629-B2 | Method for obtaining 5-amino-2,3-dihydrophthalazine-1,4-dione alkali metal salts and their use in medicine | ABIDOPHARMA PL SP. Z O.O. (PL) | 2015-08-11 | — | — | US | claimed |
| US-20140113902-A1 | METHOD FOR OBTAINING 5-AMINO-2,3-DIHYDROPHTHALAZINE-1,4-DIONE ALKALI METAL SALTS AND THEIR USE IN MEDICINE | Abidopharma PL SP. Z.O.O. (PL) | 2014-04-24 | — | — | US | claimed |
| US-8536171-B2 | Method for obtaining 5-amino 2,3-dihydrophthalazine-1,4-dione alkali metal salts and their use in medicine | Abidopharma PL SP. Z.O.O. (PL) | 2013-09-17 | — | — | US | claimed |
| EP-2389364-A2 | NEW METHOD FOR OBTAINING 5-AMINO-2,3-DIHYDROPHTHALAZINE-1,4-DIONE ALKALI METAL SALTS AND THEIR USE IN MEDICINE | Abidopharma Pl SP. Z.O.O (PL) | 2011-11-30 | — | — | EP | claimed |
| US-20110275642-A1 | NEW METHOD FOR OBTAINING 5-AMINO 2,3-DIHYDROPHTHALAZINE-1,4-DIONE ALKALI METAL SALTS AND THEIR USE IN MEDICINE | Abidopharma PL SP. Z.O.O. (PL) | 2011-11-10 | — | — | US | claimed |
| US-8039605-B2 | Targeting of long chain triacylglycerol hydrolase gene for tuberculosis treatment | UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) | 2011-10-18 | — | — | US | claimed |
| WO-2010082858-A2 | NEW METHOD FOR OBTAINING 5-AMINO-2,3-DIHYDROPHTHALAZINE-1,4-DIONE ALKALI METAL SALTS AND THEIR USE IN MEDICINE | ABIDOPHARMA PL SP. Z.O.O (PL) | 2010-07-22 | — | — | WO | claimed |
| EP-2389364-B1 | NEW METHOD FOR OBTAINING 5-AMINO-2,3-DIHYDROPHTHALAZINE-1,4-DIONE ALKALI METAL SALTS AND THEIR USE IN MEDICINE | ABIDOPHARMA PL SP Z O O (PL) | 2016-10-26 | — | — | EP | disclosed |
| EP-3072888-A1 | USE OF 5-AMINO-2,3-DIHYDROPHTHALAZINE-1,4-DIONE ALKALI METAL SALTS IN MEDICINE | Abidopharma PL Sp. z o.o. (PL) | 2016-09-28 | — | — | EP | disclosed |
| US-9101629-B2 | Method for obtaining 5-amino-2,3-dihydrophthalazine-1,4-dione alkali metal salts and their use in medicine | ABIDOPHARMA PL SP. Z O.O. (PL) | 2015-08-11 | — | — | US | disclosed |
| US-20140113902-A1 | METHOD FOR OBTAINING 5-AMINO-2,3-DIHYDROPHTHALAZINE-1,4-DIONE ALKALI METAL SALTS AND THEIR USE IN MEDICINE | Abidopharma PL SP. Z.O.O. (PL) | 2014-04-24 | — | — | US | disclosed |
| US-8536171-B2 | Method for obtaining 5-amino 2,3-dihydrophthalazine-1,4-dione alkali metal salts and their use in medicine | Abidopharma PL SP. Z.O.O. (PL) | 2013-09-17 | — | — | US | disclosed |
| EP-2389364-A2 | NEW METHOD FOR OBTAINING 5-AMINO-2,3-DIHYDROPHTHALAZINE-1,4-DIONE ALKALI METAL SALTS AND THEIR USE IN MEDICINE | Abidopharma Pl SP. Z.O.O (PL) | 2011-11-30 | — | — | EP | disclosed |
| US-20110275642-A1 | NEW METHOD FOR OBTAINING 5-AMINO 2,3-DIHYDROPHTHALAZINE-1,4-DIONE ALKALI METAL SALTS AND THEIR USE IN MEDICINE | Abidopharma PL SP. Z.O.O. (PL) | 2011-11-10 | — | — | US | disclosed |
| US-8039605-B2 | Targeting of long chain triacylglycerol hydrolase gene for tuberculosis treatment | UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) | 2011-10-18 | — | — | US | disclosed |
| WO-2010082858-A2 | NEW METHOD FOR OBTAINING 5-AMINO-2,3-DIHYDROPHTHALAZINE-1,4-DIONE ALKALI METAL SALTS AND THEIR USE IN MEDICINE | ABIDOPHARMA PL SP. Z.O.O (PL) | 2010-07-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110275642-A1 | NEW METHOD FOR OBTAINING 5-AMINO 2,3-DIHYDROPHTHALAZINE-1,4-DIONE ALKALI METAL SALTS AND THEIR USE IN MEDICINE | ADH1C, SCN5A, ADH1A | ALDH1A1 91/4885PARP1 3637/4885TDP1 1418/4885 |
| US-20140113902-A1 | METHOD FOR OBTAINING 5-AMINO-2,3-DIHYDROPHTHALAZINE-1,4-DIONE ALKALI METAL SALTS AND THEIR USE IN MEDICINE | SCN5A, SLC5A2, KCNJ2 | ALDH1A1 1348/4885PARP1 3505/4885TDP1 2060/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.